Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18922516

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer : JCOG 9702

Author
OKAMOTO, H1 ; WATANABE, K1 ; KUNIKANE, H1 ; YOKOYAMA, A2 ; KUDOH, S3 ; ASAKAWA, T4 ; SHIBATA, T4 ; KUNITOH, H5 ; TAMURA, T5 ; SAIJO, N6
[1] Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama, Kanagawa 240-8555, Japan
[2] Niigata Cancer Center Hospital, Niigata-city, Japan
[3] Osaka City University Medical School, Osaka-city, Japan
[4] National Cancer Center, Tokyo, Japan
[5] National Cancer Center Hospital, Tokyo, Japan
[6] National Cancer Center East Hospital, Kashiwa, Japan
Japan Clinical Oncology Group (JCOG)-Lung Cancer Study Group, Japan
Source

British journal of cancer. 2007, Vol 97, Num 2, pp 162-169, 8 p ; ref : 3/4 p

CODEN
BJCAAI
ISSN
0007-0920
Scientific domain
Medical oncology
Publisher
Nature Publishing Group, Basingstoke
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
carboplatin cisplatin elderly etoposide poor-risk small-cell lung cancer
Keyword (fr)
Anticancéreux Cancer du poumon Cancérologie Carboplatine Carcinome petite cellule bronchopulmonaire Chimiothérapie Cisplatine Dose Epidémiologie Essai clinique phase III Essai clinique Etoposide Etude comparative Facteur risque Personne âgée Traitement Inhibiteur de la topoisomérase II Agent alkylant Antimitotique Appareil respiratoire pathologie Bronche pathologie DNA topoisomerase (ATP-hydrolysing) Enzyme Homme Inhibiteur enzyme Isomerases Platine II Complexe Podophyllotoxine dérivé Poumon pathologie Tumeur maligne
Keyword (en)
Antineoplastic agent Lung cancer Cancerology Carboplatin Bonchopulmonary small cell carcinoma Chemotherapy Cisplatin Dose Epidemiology Phase III trial Clinical trial Etoposide Comparative study Risk factor Elderly Treatment Alkylating agent Antimitotic Respiratory disease Bronchus disease DNA topoisomerase (ATP-hydrolysing) Enzyme Human Enzyme inhibitor Isomerases Platinum II Complexes Podophyllotoxine derivatives Lung disease Malignant tumor
Keyword (es)
Anticanceroso Cáncer del pulmón Cancerología Carboplatino Carcinoma pequeňa célula bronchopulmonar Quimioterapia Cisplatino Dosis Epidemiología Ensayo clínico fase III Ensayo clínico Etopósido Estudio comparativo Factor riesgo Anciano Tratamiento Agente alquilante Antimitótico Aparato respiratorio patología Bronquio patología DNA topoisomerase (ATP-hydrolysing) Enzima Hombre Inhibidor enzima Isomerases Platino II Complejo Podofilotoxina derivado Pulmón patología Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum

Discipline
Pulmonology Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
18922516

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web